Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant's bid to win a slice of ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

But the exact mechanisms of how the drug works in the brain in doing things like tamping down food noise, addiction, and now, ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

One popular and affordable supplement that has shown some promise in helping with weight loss is berberine. In fact, some ...

Secretary Robert F. Kennedy Jr. said he is considering a “regulatory framework” for Medicare and Medicaid to cover GLP-1 ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.